By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.
Cornell researchers have identified a key protein mechanism that helps bacteria expel antibiotics, making them more resistant ...
A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...
AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...
Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled ...
Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...
Three of these six pathogens are antibiotic-resistant Gram-negative bacteria. Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13 ...
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback